Busca avançada
Ano de início
Entree
(Referência obtida automaticamente do Web of Science, por meio da informação sobre o financiamento pela FAPESP e o número do processo correspondente, incluída na publicação pelos autores.)

Risk of false conformity assessment applied to automotive fuel analysis: A multiparameter approach

Texto completo
Autor(es):
de Oliveira, Elcio Cruz [1, 2] ; Lourenco, Felipe Rebello [3]
Número total de Autores: 2
Afiliação do(s) autor(es):
[1] Rio de Janeiro Catholic Univ, Posgrad Metrol Programme, Marques Sao Vicente St 225, Rio De Janeiro - Brazil
[2] PETROBRAS TRANSPORTE SA, Technol Management & Automat, Rio De Janeiro - Brazil
[3] Univ Sao Paulo, Fac Ciencias Farmaceut, Dept Farm, Programa Pos Grad Farmaco & Medicamentos, Sao Paulo - Brazil
Número total de Afiliações: 3
Tipo de documento: Artigo Científico
Fonte: Chemosphere; v. 263, JAN 2021.
Citações Web of Science: 0
Resumo

The low-quality of automotive fuels may lead to the generation of pollutants harmful to both environmental and human health. The quality evaluation of automotive fuels requires a multiparameter conformity assessment, which may lead to an increased total risk of false conformity decisions even if all parameters comply with the acceptance limits. Thus, the aim of this work was to propose the establishment of multivariate acceptance limits in order to ensure a reduced total risk of false conformity decisions applied to automotive fuels analysis. Particular and total (consumers' and/or producers') risks were estimated using frequentist (specific) and Bayesian (global) approaches. Multivariate acceptance limits were estimated using Monte Carlo method, adopting an appropriate multivariate coverage factor (k') defined using MS Excel Solver function. The definition of multivariate acceptance limits ensures a total risk below the maximum admissible risk (typically 5%) and was successfully employed in the conformity assessment of automotive fuels (diesel and gasoline). The employment of the multivariate acceptance limits may be useful in the conformity assessment of several multiparameter products. (C) 2020 Elsevier Ltd. All rights reserved. (AU)

Processo FAPESP: 19/16206-3 - Riscos de decisões falsas quanto a avaliação de equivalência farmacêutica devido as incertezas de medições
Beneficiário:Felipe Rebello Lourenço
Modalidade de apoio: Auxílio à Pesquisa - Regular